RT
RadioNano Therapeutics
Japan · Biotech
RadioNano Therapeutics develops boron-containing nanoparticle medicines for boron neutron capture therapy.
Product
Its lead candidate, RN-501, uses boron-rich inorganic nanoparticles designed to concentrate the treatment material in cancer tissue. Neutron exposure triggers a localized nuclear reaction in the boron, providing the underlying mechanism for the therapy.
The Kyoto University spinout is advancing the formulation toward clinical testing. RN-501 remains investigational, with its safety and effectiveness yet to be established in people.
- Lead candidate
- RN-501
- Technology
- Boron neutron capture therapy
Funding history
1 round · 0 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B first close | Undisclosed | Innovation Kyoto 2021 Investment Limited Partnership — ParticipantMitsui Kinzoku — Participant |